Head injury: assessment and early management
Expected publication date: 23 February 2023
This guidance will partially update the previous NICE guidance on head injury CG176.
The consultation the draft guidance is due to take place 26 August - 07 October 2022.
Rehabilitation for Chronic Neurological Disorders Including Traumatic Brain Injury (GID-NG10181)
Expected publication date: 13 December 2023
The consultation on the draft scope took place in June / July 2022.
School-based interventions: physical and mental health and wellbeing promotion (GID-QS10070)
Expected publication date: TBC
Schedule affected by Covid-19
Weight Management: preventing, assessing and managing overweight and obesity (update) (GIG - 10182)
Expected publication date: 22 June 2023
This guidance will partially update existing NICE guidance.
The draft guidance consultation is due 23 December 2022 - 08 February 2023.
Dr Grace O'Mally is on the committee: a paediatric physiotherapist and clinical researcher specialising in childhood obesity and exercise science.
Obesity: identification and classification of overweight and obesity – update (GID-NG1028)
Expected publication date: 08 September 2022
As part of development of the NICE guideline on Weight Management, NICE are updating CG189 and are focusing on the identification and classification of overweight and obesity.
APCP is grateful to Jen Chesterton who collated and submitted comments on behalf of APCP members on the the draft guideline.
Weight Management
Weight Management – https://www.nice.org.uk/guidance/indevelopment/gid-ng10182/documents
This guideline includes management in children and young people. The consultation on the draft guidance has now closed and it is in committee stage. Final publication of the guidance is due by 27th March 2024.
Meningitis guidance in development
Guidance in development
Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and management This guideline https://www.nice.org.uk/guidance/indevelopment/gid-ng10149/documents includes the management of babies and children and long-term complications and follow-up for bacterial meningitis and meningococcal disease. Expected final publication was delayed and is now expected on 14 March 2024.
Quality standards in development
Quality standards in development
Quality standards are standards against which NHS trusts can measure their adherence to NICE guidance. These are developed after the Guidance documents on topics are published.
In Committee stage being developed:
Obesity: clinical assessment and management (QS update) Consultation has just closed and the expected publication date is 11 December 2024. You can view information about the standards and the consultation here: https://www.nice.org.uk/guidance/indevelopment/gid-qs10183/consultation/html-content
Guidance in consultation
Consultation and publication dates to be confirmed.
· School based interventions: physical and mental health and wellbeing promotion · https://www.nice.org.uk/guidance/indevelopment/gid-qs10070
· Children and young people with disabilities and severe complex needs: integrated health and social care support https://www.nice.org.uk/guidance/awaiting-development/gid-qs10146
· Infant, children and young people's experience of health care https://www.nice.org.uk/guidance/awaiting-development/gid-qs10102
· Pain management (young people and adults) https://www.nice.org.uk/guidance/awaiting-development/gid-qs10093
Rehabilitation for Chronic Neurological Disorders Including Traumatic Brain Injury
This will include children and young people. The final scope document from which the committee will develop the guidance has been published insert link: https://www.nice.org.uk/guidance/gid-ng10181/documents/final-scope and the guidance is being developed in committee. Consultation on the draft guidance appears to have been postponed. The final guidance document is due to be published on 15 January 2025.
Epilepsy
Epilepsy – extraordinary review expected publication date to be confirmed. This is to review Valproate prescribing in children and adults under 55 years.